Now showing items 1-1 of 1

    • Thumbnail

      Soluble urokinase plasminogen activator receptor (suPAR) levels predict damage accrual in patients with recent-onset systemic lupus erythematosus 

      Enocsson, Helena; Wirestam, Lina; Dahle, Charlotte; Padyukov, Leonid; Jonsen, Andreas; Urowitz, Murray B; Gladman, Dafna D; Romero Díaz, Juanita; Bae, Sang Cheol; Fortin, Paul R.; Sánchez Guerrero, Jorge; Clarke, Ann E; Bernatsky, Sasha; Gordon, Caroline; Hanly, John G; Wallace, Daniel J; Isenberg, David A; Rahman, Anisur; Merrill, Joan T; Ginzler, Ellen; Alarcón, Graciela S; Chatham, W Winn; Petri, Michelle; Khamashta, Munther; Aranow, Cynthia; Mackay, Meggan; Dooley, Mary Anne; Manzi, Susan; Ramsey Goldman, Rosalind; Nived, Ola; Steinsson, Kristjan; Zoma, Asad A; Ruiz Irastorza, Guillermo; Lim, S Sam; Kalunian, Kenneth C; Inanc, Murat; van Vollenhoven, Ronald F; Ramos Casals, Manuel; Kamen, Diane L; Jacobsen, Soren; Peschken, Christine A; Askanase, Anca; Stoll, Thomas; Bruce, Ian N; Wettero, Jonas; Sjowall, Christopher (Elsevier, 2019-10-17)
      OBJECTIVE: The soluble urokinase plasminogen activator receptor (suPAR) has potential as a prognosis and severity biomarker in several inflammatory and infectious diseases. In a previous cross-sectional study, suPAR levels ...